NCT05640102 2026-03-04Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström MacroglobulinemiaBeOne MedicinesRecruiting111 enrolled
NCT06441214 2026-01-05Retrospective-prospective Study to Evaluate Treatment Management and Outcomes of Patients With Waldenström's Macroglobulinemia (WM) Treated in Italy According to the Zanubrutinib (Brukinsa®) Compassionate Use Program (CUP) and in Common Practice Following Commercial Approval.Fondazione Italiana Linfomi - ETSActive not recruiting212 enrolled